ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AbbVie and Calibr partner to develop T-cell therapies for cancer
pharmaceutical-technology
June 28, 2018AbbVie has formed an alliance with Scripps Research’s non-profit drug discovery unit Calibr to develop next-generation T-cell therapies that are aimed at targeting various cancers, including solid tumours. -
GSK makes T-cell move
pharmatimes
September 11, 2017GSK has exercised its option to exclusively license the right to research, develop, and commercialise Adaptimmune's NY-ESO SPEAR T-cell therapy programme, from a collaboration and license agreement signed in 2014. -
Artificial T-cell receptors market
pharmaasia
July 04, 2017Futuristic application of Therapeutics expecting 44% CAGR during 2016-2023: Occams Business Research & Consulting Pvt. Ltd.
Pharma Sources Insight January 2025
